Monsanto pulls Canada wheat plans

Roundup Ready wheat development discontinued in the face of Wheat Board opposition

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Monsanto announced Monday (May 10) that it is discontinuing development of Roundup Ready wheat, its genetically modified (GM) herbicide-resistant wheat. Instead of going forward with the commercialization of the wheat strains, developed with the help of the federal government's Agriculture Canada, Monsanto said it would monitor the progress other biotech companies make in developing traits that would make GM wheat more commercially viable.

“We'll be looking for progress in disease-resistant traits, stress tolerance traits—the list goes on and on,” Monsanto Canada spokesperson Trish Jordon told The Scientist. Jordon said it might take between 4 and 8 years before research yields results that would warrant another look at GM wheat. “Until there is a first trait on the market, we won't initiate work on a second trait. Maybe somebody else will be treated differently than we were treated as a company,” she said.

Monsanto was not treated gently, as various activist ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ed Ungar

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours